PROS1 and COVID-19: However, opposing results have been reported by Walsh and colleagues, who compared two mRNA-based COVID-19 vaccine and showed that the BNT162b2 vaccine, encoding the entire length-S protein was associated with a lower incidence and severity of systemic reactions than the BNT162b1encoding the RBD of the S protein (182).